1997 Archived News

Additional Reports of Liver Damage and Rezulin Lead to Further Revisions in Use Guidelines : [December, 1997] — The U.S. Food and Drug Administration this week announced that patients taking the diabetes drug Rezulin (troglitazone) should be monitored even more frequently for signs of injury to the liver.
Reports of Liver Damage and Rezulin Lead to Revised Use Guidelines : [November, 1997] — Recent reports of severe liver damage in two individuals taking the new type 2 diabetes medication troglitazone (Rezulin) mean that physicians will need to test liver functions of patients on the drug at regular intervals.
Study Suggests Chromium Helps Control Diabetes : [November, 1997] — The November issue of the journal Diabetes reports that large doses of the trace element chromium may help patients with type 2 diabetes significantly lower their blood sugar and cholesterol levels.